Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
SCHAUMBURG, Ill., Feb. 03, 2016 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) a leader of specialty pharmaceutical products with a specific emphasis on the injectable market, today...
-
SCHAUMBURG, Ill., Jan. 12, 2016 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) announced its GLYDO® (lidocaine HCl jelly USP, 2%) has received Innovative Technology designation from...
-
SCHAUMBURG, Ill., Jan. 08, 2016 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today...
-
Company Affirms 2015 Full Year Guidance Allan Oberman Assumes Role of Chief Executive Officer effective September 12, 2015 SCHAUMBURG, Ill., Nov. 03, 2015 (GLOBE NEWSWIRE) -- Sagent...
-
SCHAUMBURG, Ill., Oct. 27, 2015 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) today announced the launch of Chlorothiazide Sodium for Injection, USP, a diuretic/antihypertensive...
-
SCHAUMBURG, Ill., Oct. 20, 2015 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) a leader of specialty pharmaceutical products with a specific emphasis on the injectable market, today...
-
Company to evaluate strategic alternatives for Sagent (China) Pharmaceuticals Company modifies earnings guidance for 2015 SCHAUMBURG, Ill., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Sagent...
-
SCHAUMBURG, Ill., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) a leader of specialty pharmaceutical products with a specific emphasis on the injectables market, today...
-
SCHAUMBURG, Ill., July 28, 2015 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT), a leader of specialty pharmaceutical products with a specific emphasis on the injectable market, today...
-
SCHAUMBURG, Ill., May 5, 2015 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with a specific emphasis on the injectable market, today...